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ABSTRACT
Diagnosing chronic inflammatory polyradiculopathy in patients with pre-existing diabetic sensorimotor polyneuropathy
is a diagnostic challenge. We present a case of a 69 years old who presented with weakness of legs for two months,he
was diagnosed as having CIDP on the background of diabetic sensorimotor polyneuropathy, further and extensive
workup revealed the final diagnosis of nonsecretory myeloma. Diagnosing non secretory myeloma is itself a diagnostic
challenge and usually first line investigations for the workup of myeloma are negative as was the case in our patient.
Our patient with CIDP had raised free light chains of kappa which made the final diagnosis of kappa associated plasma
cell dyscrasia.
Key words: Chronic inflammatory polyradiculopathy (CIDP), Non secretory myeloma, Diabetic sensorimotor
neuropathy
INTRODUCTION

months and was driving. The weakness was
asymmetrical and involved left leg more than right and
involved both proximal and distal muscles equally and
at the same time. He denied any symptoms in upper
limbs. There was no significant backache or urinary
symptoms. There was longstanding numbness in both
his feet for more than six years which was unchanged.
Examination revealed wasting of left leg, marked
ischemic lower limbs skin changes, diabetic foot ulcer
on right first metatarsal. There was prominent wasting
of small muscles in hands as well. Power was 4/5 on
left leg both proximally and distally. Power was 4+ on
right leg both proximally and distally. He had normal
power in upper limbs.Sensory system examination
revealed impaired pin prick sensation in gloves and
stocking distribution, impaired vibration and position
sense in legs upto ankles.Investigations revealed HB of
10.5g/dL microcytic hypochromic.His renal functions
revealed creatinine of 2.7mg/dL and urea of 40mg/dL.
Serum electrolytes showed low sodium of 128mmol/L,
normal potassium and low bicarbonate of 16. His
HbA1c was 8.7.His nerve conduction studies and
Electromyography revealed changes suggestive of
sensorimotor predominantly polyneuropathy with
demyelination changes as shown in figure 1&2.Was it
just the rapid progression of Diabetic Sensorimotor

Chronic inflammatory polyradiculopathy (CIDP) is
clinically defined as ‘chronically progressive, stepwise
or recurrent proximal and distal and sensory
dysfunction of all extremities, developing over at least
02 months, with absent or reduced tendon reflexes in
all limbs and sometimes with cranial nerve
involvement[1].The diagnosis of CIDP in diabetes
patients may be significantly more difficult than in
non-diabetics, due to mild demyelinating changes
associated with diabetic sensorimotor polyneuropathy
(DSP), in the setting of poor glycemic control[2].We
present such a challenging case of 69 year old male
from Islamabad where reaching to a final diagnosis was
an arduous journey and in itself was a diagnostic
challenge.
CASE REPORT:
A 69 years old male with 35 years long history of type
2 diabetes Mellitus with complications of diabetic
neuropathy, nephropathy CKD III, retinopathy, diabetic
foot ulcer presented with two months history of gradual
but rapid worsening of weakness in both legs, he was
independent with activities of daily living prior to two
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Figure1.Nerve conduction studies of the patient showing prolonged distal latencies, reduced
amplitudes and reduced conduction velocities of majority of upper limb nerves. Majority of
lower limb nerves show no response. Sensory nerves are affected as well.
Polyneuropathy or this presentation suggestive of CIDP
was the main diagnostic dilemma here. Diagnosing
CIDP is a challenge in diabetics with pre-existing
sensorimotor
polyneuropathy.Our
patient
had
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neurological deterioration in 02 months and had raised
CSF proteins of 136.6mg/dl which further supported
the diagnosis of CIDP and there was evidence of
demyelination on nerve conduction studies, however
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Figure 2. Electromyography of the patient showing neuropathic changes in form of broad motor
unit potentials, some showing high amplitude and reduced interference pattern.
exact electrophysiological criteria could not be applied
due to the presence of diabetic sensorimotor
polyneuropathy.Rest of the diagnostic workup showed
negative antiganglioside antibodies including Anti GM1
antibodies. His ANA, ENA(extractable nuclear antigen
antibodies) were negative. His serum electrophoresis
was normal, showing no evidence of para proteins. ESR
was 49 and CRP was negative. MRI lumbosacral spine
showed mild to moderate lumbar spondylosis as shown
in figure 3.IVIG were contraindicated in our patient due
to diabetes associated renal impairment. As oral
corticosteroids are considered as first line treatment of
newly diagnosed CIDP, patient was started on steroids.
Plasma exchange was high risk in our patient due to
presence of cardiovascular compromise and was
offered but refused by patient. Patient was given
corticosteroids along with Azathioprine for 06 weeks. At
06 weeks he showed no improvement in his disability.
However, he further developed malena, steroid induced
gastropathy was confirmed on endoscopy which
confirmed marked antral gastritis and gastric erosions.
His haemoglobin dropped from 10.5 to 7.5 mg/dL. He
also developed neutropenia probably due to
azathioprine and developed marked oral ulcers and
thrush rendering him nil by mouth. Steroids and

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

azathioprine were therefore discontinued. As patient
did not respond to first line treatment and we had
difficulties with first line treatments. We underwent
second-line investigations. Further diagnostic workup
revealed raised serum free light chain. Free kappa were
found to be >4380mg/L (range 3.3-19.4mg/L).Serum
protein electrophoresis of the patient was normal but
the serum light chains were very high making the final
diagnosis of non secretory myeloma. So final diagnosis
was non secretory Kappa plasma cell dyscrasia
DISCUSSION
Diabetes patients who have changes suggestive of
demyelination on nerve conduction studies (NCS) are
usually considered to have a superimposed
immune-mediated polyneuropathy, such as chronic
inflammatory demyelinating polyneuropathy (CIDP)[3].
The differentiation of CIDP from DSP in patients with
diabetes is important due to the implications for
therapy and prognosis[4]. The finding of raised CSF
proteins helped us in making the diagnosis of CIDP. In
such difficult cases finding of raised CSF proteins
without CSF leucocytosis further supports the diagnosis
of CIDP[1] and this is next important investigation to

35

VOL. 11 (3) JUL

-

SEP

2016

Figure 3.MRI lumbosacral spine of the patient showing mild to moderate lumbar spondylosis.
undertake in this regard.The quality of evidence for the
efficacy for intravenous immunoglobulin and plasma
exchange is moderate to high, with plasma exchange
providing significant short term improvement in
disability, clinical impairment and motor nerve
conduction velocities, although there may be rapid
deterioration post exchange[5]. Seventy percent of
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patients of CIDP respond to one or another of the three
standard therapies and probably 90% respond overall
l[1]. The lack of response to treatment and minimal
electrophysiological progressin over time should lead
one to suspect the diagnosis and undergo
secondlineinvestigations[1]. Same was the case in our
patient, he did not respond to steroids so we opted for
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second line investigations and further extensive workup
which revealed diagnosis of non secretory myeloma.
Serum protein electrophresis has only a 60% sensitivity
for detecting paraproteins in the context of neuropathy,
so immunofixaton,95% sensitivity along with bence
jones proteins and serum free light chains should be
performed[1]. Non secretory myeloma are one of the
rare cause of myeloma found in only 1 to 5% of the
cases of multiple myeloma[6].They often present as
diagnostic challenge[6].
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CONCLUSION
We conclude that diagnosing CIDP in patients with
background diabetic sensorimotor neuropathy is a
diagnostic challenge.We also recommend diagnostic
workup for myeloma in CIDP should not just include
serum and urine electrophoresis but should include
immunofixation as well as serum free light chains ratio
especially if the response to first line therapy is
poor.More than meets the eye,never stop at any step,
keep on looking for the rare causes which can make a
single unifying diagnosis of all symptoms, as in this
case of non secretory myeloma
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